Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ThromboGenics NV

+ Add to Watchlist

THR:BB

5.3030 EUR 0.1100 2.03%

As of 11:35:00 ET on 05/05/2015.

Company Profile for ThromboGenics NV (THR)

ThromboGenics NV is a biopharmaceutical company focused on the development of therapeutics for conditions related to the vascular system. The Company is focused on developing medicines to treat visual disorders, cardiovascular diseases, and cancer, conditions which result from abnormalities to the vascular system.

Contact Information

ThromboGenics NV

Gaston Geenslaan 1
B-3001
Heverlee
Belgium
Phone: 32-16-75-13-10
Fax: 32-16-75-13-11

Key Executives for ThromboGenics NV (THR)

Patrik De HaesCEO/Executive DirectorDominique VanfleterenChief Financial Officer
Claude SanderChief Legal OfficerLaurence RaemdonckHead:Human Resources
Andy De DeeneHead:Clinical & Product DevAniz GirachHead:Clinical Ophthalmology
David PearsonHead:Corporate DevEdward F KessigHead:US Commercial Ops
Jean FeyenHead:Preclinical Research

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil